Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningBone MarrowStem Cell TransplantationHematopoietic Stem Cell MobilizationHematologic NeoplasmsBone Marrow CellsGraft SurvivalHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorStem CellsWhole-Body IrradiationBusulfanCombined Modality TherapyTransplantation ChimeraTissue DonorsCyclophosphamideLeukapheresisMelphalanAntigens, CD34Treatment OutcomeLeukemiaRecurrenceHistocompatibility TestingHistocompatibilityAnemia, AplasticMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalRemission InductionLiver TransplantationTransplantation, IsogeneicCord Blood Stem Cell TransplantationLymphoma, Non-HodgkinImmunosuppressive AgentsHematopoiesisMyeloablative AgonistsBone Marrow PurgingRetrospective StudiesBone and BonesTime FactorsLeukemia, Myeloid, AcuteKidney TransplantationEtoposideLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisDisease-Free SurvivalCytomegalovirus InfectionsBone Marrow DiseasesSurvival RateInfectionPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionAntineoplastic Agents, AlkylatingGraft vs Leukemia EffectMyelodysplastic SyndromesCarmustineImmunosuppressionCytarabineSalvage TherapyHematologic DiseasesThiotepaHodgkin DiseaseHLA AntigensCyclosporineTransplantation ImmunologyOpportunistic InfectionsFollow-Up StudiesGraft RejectionAcute DiseaseVidarabineHepatic Veno-Occlusive DiseaseBlood CellsFatal OutcomeLymphomaT-LymphocytesVincristineLeukocyte TransfusionMice, Inbred C57BLPlatelet CountCell DifferentiationHeart TransplantationPOEMS SyndromeLeukemia, MyeloidMesenchymal Stem Cell TransplantationTransplantationBlood Cell CountColony-Forming Units AssayAmyloidosisLymphocyte TransfusionFlow CytometryImmunophenotypingProspective StudiesLung TransplantationNeoplasms